Beijing Winsunny Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100005QF9
CNY
23.30
0.96 (4.3%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
886.63
792.82
830.47
898.62
891.53
852.77
802.72
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
886.63
792.82
830.47
898.62
891.53
852.77
802.72
Raw Material Cost
310.60
280.34
286.81
303.36
294.55
287.54
281.33
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.33
0.42
0.52
0.70
0.80
1.03
0.97
Selling and Distribution Expenses
344.46
271.99
337.27
376.62
376.38
300.60
324.45
Other Expenses
11.08
8.58
6.84
11.55
10.38
10.22
7.48
Total Expenditure (Excl Depreciation)
766.21
638.57
693.02
796.22
775.54
691.40
681.54
Operating Profit (PBDIT) excl Other Income
120.39999999999999
154.3
137.5
102.4
116
161.4
121.19999999999999
Other Income
7.03
6.70
16.13
20.50
10.95
21.59
34.24
Operating Profit (PBDIT)
116.68
189.18
176.41
133.95
141.91
198.77
176.14
Interest
0.33
0.42
0.52
0.70
0.80
1.03
0.97
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
576.03
512.49
543.66
595.26
596.98
565.23
521.39
Depreciation
0.00
31.56
31.56
26.43
26.43
27.14
27.14
Profit Before Tax
116.35
157.20
144.32
106.81
114.68
170.59
148.03
Tax
7.03
19.53
13.52
18.82
3.04
11.68
14.50
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
107.47
137.23
130.63
87.73
110.33
158.04
132.58
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
107.47
137.23
130.63
87.73
110.33
158.04
132.58
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
1.85
0.43
0.17
0.27
1.31
0.87
0.95
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
109.32
137.67
130.81
88.00
111.64
158.91
133.52
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,685.35
3,577.93
3,674.75
3,544.56
3,456.85
3,375.18
3,452.19
Earnings per share (EPS)
0.23
0.29
0.28
0.19
0.24
0.34
0.28
Diluted Earnings per share
0.23
0.29
0.28
0.19
0.24
0.34
0.28
Operating Profit Margin (Excl OI)
12.37%
19.04%
15.5%
9.68%
11.72%
17.59%
14.3%
Gross Profit Margin
13.12%
23.81%
21.18%
14.83%
15.83%
23.19%
21.82%
PAT Margin
12.12%
17.31%
15.73%
9.76%
12.38%
18.53%
16.52%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Sep 2025 is -0.55% vs 7.01% in Sep 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Sep 2025 is -2.06% vs -14.68% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2025 is -16.34% vs -17.71% in Sep 2024

stock-summary

Interest

YoY Growth in quarter ended Sep 2025 is -62.50% vs -38.46% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024

Compare Quarterly Results Of Beijing Winsunny Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
886.63
0
886.63
Other Operating Income
0.00
0.00
0.00
Total Operating income
886.63
0
886.63
Raw Material Cost
310.60
0
310.60
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.33
0
0.33
Selling and Distribution Expenses
344.46
0
344.46
Other Expenses
11.08
0.00
11.08
Total Expenditure (Excl Depreciation)
766.21
0
766.21
Operating Profit (PBDIT) excl Other Income
120.43
0.00
120.43
Other Income
7.03
0
7.03
Operating Profit (PBDIT)
116.68
0
116.68
Interest
0.33
0
0.33
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
576.03
0
576.03
Depreciation
0.00
0
0.00
Profit Before Tax
116.35
0
116.35
Tax
7.03
0
7.03
Provisions and contingencies
0
0
0.00
Profit After Tax
107.47
0
107.47
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
107.47
0
107.47
Share in Profit of Associates
0
0
0.00
Minority Interest
1.85
0
1.85
Other related items
0.00
0.00
0.00
Consolidated Net Profit
109.32
0
109.32
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,685.35
0
3,685.35
Earnings per share (EPS)
0.23
0
0.23
Diluted Earnings per share
0.23
0
0.23
Operating Profit Margin (Excl OI)
12.37%
0%
0.00
12.37%
Gross Profit Margin
13.12%
0%
0.00
13.12%
PAT Margin
12.12%
0%
0.00
12.12%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 88.66 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 11.83% vs -4.54% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -0.55% vs 7.01% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 10.93 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -20.62% vs 5.28% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -2.06% vs -14.68% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 10.96 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -39.95% vs 13.85% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -16.34% vs -17.71% in Sep 2024

Quarterly - Interest
Interest 0.03 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -25.00% vs -20.00% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -62.50% vs -38.46% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.37%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024